Immitra Bio is developing a platform for scalable, one-time curative in-vivo gene editing therapies based on its novel mutation-agnostic gene editing technology and digital target identification platform. The company is developing in-vivo gene editing therapies that do not require complex ex-vivo cell manipulation, patient conditioning, or stem cell transplantation.
Investment Rounds
Capital activity and funding progression
Industries
Frequently Asked Questions
Where is Immitra Bio located?
Immitra Bio is located in Plan-les-Ouates, Switzerland.
What industries does Immitra Bio operate in?
Immitra Bio operates in the following industries: biotechnology, gene editing, therapeutics.
Who are the investors in Immitra Bio?
The investors in Immitra Bio are: Backbone Ventures, OCCIDENT, Another VC, Kickfund, Venture Kick, Zürcher Kantonalbank, FONGIT, ETH Foundation.